Cargando…
Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244507/ https://www.ncbi.nlm.nih.gov/pubmed/32444699 http://dx.doi.org/10.1038/s41598-020-65482-3 |
_version_ | 1783537588081000448 |
---|---|
author | Primiano, Guido Abed, Edoardo Corbo, Giovanni Minnella, Angelo Maria Servidei, Serenella Vollono, Catello Savastano, Maria Cristina Falsini, Benedetto |
author_facet | Primiano, Guido Abed, Edoardo Corbo, Giovanni Minnella, Angelo Maria Servidei, Serenella Vollono, Catello Savastano, Maria Cristina Falsini, Benedetto |
author_sort | Primiano, Guido |
collection | PubMed |
description | The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than rods. A cohort of twenty-two patients with genetically-defined mitochondrial diseases (MDs) were enrolled to determine if the macula is functionally and anatomically impaired in these metabolic disorders. Visual acuity and fERG amplitude of patients with primary mitochondrial dysfunction were reduced compared to controls. Furthermore, SD-OCT layer segmentation showed a reduction of retinal and outer nuclear layer (ONL) volume in the macula of the patients. fERG amplitude showed a positive correlation with both ONL volume and thickness. A negative relationship was noted between fERG amplitude and disease severity assessed with Newcastle Mitochondrial Disease Adult Scale. In conclusion, MDs are associated with functional and anatomical alteration of macular cone system, characterized by its strong correlation with clinical disease severity suggesting a role as a potential biomarker of primary mitochondrial disorders. |
format | Online Article Text |
id | pubmed-7244507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72445072020-05-30 Macular impairment in mitochondrial diseases: a potential biomarker of disease severity Primiano, Guido Abed, Edoardo Corbo, Giovanni Minnella, Angelo Maria Servidei, Serenella Vollono, Catello Savastano, Maria Cristina Falsini, Benedetto Sci Rep Article The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than rods. A cohort of twenty-two patients with genetically-defined mitochondrial diseases (MDs) were enrolled to determine if the macula is functionally and anatomically impaired in these metabolic disorders. Visual acuity and fERG amplitude of patients with primary mitochondrial dysfunction were reduced compared to controls. Furthermore, SD-OCT layer segmentation showed a reduction of retinal and outer nuclear layer (ONL) volume in the macula of the patients. fERG amplitude showed a positive correlation with both ONL volume and thickness. A negative relationship was noted between fERG amplitude and disease severity assessed with Newcastle Mitochondrial Disease Adult Scale. In conclusion, MDs are associated with functional and anatomical alteration of macular cone system, characterized by its strong correlation with clinical disease severity suggesting a role as a potential biomarker of primary mitochondrial disorders. Nature Publishing Group UK 2020-05-22 /pmc/articles/PMC7244507/ /pubmed/32444699 http://dx.doi.org/10.1038/s41598-020-65482-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Primiano, Guido Abed, Edoardo Corbo, Giovanni Minnella, Angelo Maria Servidei, Serenella Vollono, Catello Savastano, Maria Cristina Falsini, Benedetto Macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
title | Macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
title_full | Macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
title_fullStr | Macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
title_full_unstemmed | Macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
title_short | Macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
title_sort | macular impairment in mitochondrial diseases: a potential biomarker of disease severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244507/ https://www.ncbi.nlm.nih.gov/pubmed/32444699 http://dx.doi.org/10.1038/s41598-020-65482-3 |
work_keys_str_mv | AT primianoguido macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT abededoardo macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT corbogiovanni macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT minnellaangelomaria macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT servideiserenella macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT vollonocatello macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT savastanomariacristina macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity AT falsinibenedetto macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity |